Back to Search
Start Over
Intravenous chlorpromazine for acute paediatric migraine.
- Source :
-
Emergency Medicine Australasia . Aug2022, Vol. 34 Issue 4, p623-625. 3p. - Publication Year :
- 2022
-
Abstract
- Objective: In paediatric migraine, ibuprofen, acetaminophen and triptans are safe, effective therapies but there is scant paediatric data informing second‐line emergency treatment. Methods: Retrospective cohort study of children diagnosed with migraine at a tertiary children's hospital ED. Results: There were 207 children with migraine over a 1 year period. 46% received simple oral analgesia. 25% intravenous chlorpromazine, of whom 45% received further analgesia. Conclusions: While intravenous chlorpromazine as second‐line agent was mostly safe, it had unclear efficacy given the requirement for further treatment and hospital admissions. [ABSTRACT FROM AUTHOR]
- Subjects :
- *DRUG efficacy
*LENGTH of stay in hospitals
*HOSPITAL emergency services
*CONFIDENCE intervals
*MIGRAINE
*ANALGESICS
*CHLORPROMAZINE
*RETROSPECTIVE studies
*ACQUISITION of data
*COMPARATIVE studies
*OXYCODONE
*MEDICAL records
*DESCRIPTIVE statistics
*INTRAVENOUS injections
*DATA analysis software
*EVALUATION
*CHILDREN
*ADOLESCENCE
Subjects
Details
- Language :
- English
- ISSN :
- 17426731
- Volume :
- 34
- Issue :
- 4
- Database :
- Academic Search Index
- Journal :
- Emergency Medicine Australasia
- Publication Type :
- Academic Journal
- Accession number :
- 158011185
- Full Text :
- https://doi.org/10.1111/1742-6723.13985